R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Background The biosimilar rituximab (Redditux) was approved in Turkey for all indications of the reference molecule (MabThera) in March 2018. Large clinical trials and real-life experiences are lacking in hematological malignancies. Aims We aimed to evaluate the efficacy and safety of Redditux in de...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2021-11, Vol.138 (Supplement 1), p.4585-4585
Hauptverfasser:	Ozbalak, Murat, Mastanzade, Metban, Ozluk, Ozden, Tiryaki, Tarik Onur, Erdem, Simge, Pınar Özbalak, Ezgi, Elverdi, Tuğrul, Yonal Hindilerden, Ipek, Yenerel, Mustafa Nuri, Soysal, Teoman, Nalcaci, Meliha, Ferhanoglu, Burhan, Kalayoglu Besisik, Sevgi
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!